Document Detail

Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
MedLine Citation:
PMID:  18781600     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Atherosclerosis is widely accepted as a chronic inflammatory disease. Research paid much attention to sensitive specific serum biomarkers for vulnerable plaques. The markers not only serve as diagnostic tools for the identification of patients with acute coronary syndrome (ACS), but also help us to identify high-risk patients. However, the existing data are limited and have been conflicting. HYPOTHESIS: Circulating interleukin-6 (IL-6), soluble CD40 ligand (sCD40L), metalloproteinase-9 (MMP-9), and tissue inhibitor of metalloproteinase-1 (TIMP-1) might correlate with the onset and the cardiac mortality of patients with ST-segment elevation myocardial infarction (STEMI). METHODS: Serum levels of IL-6, sCD40L, MMP-9, and TIMP-1 were measured by sandwich enzyme-linked immunosorbent assay (ELISA) in 263 patients with STEMI and 262 age- and gender-matched control subjects without coronary artery disease (CAD). The patients with STEMI were then followed prospectively for 24 mo for the occurrence of cardiac mortality. RESULTS: Compared with the control subjects, patients with STEMI exhibited higher levels of IL-6 (p<0.001), sCD40L (p<0.001), MMP-9 (p<0.001), TIMP-1 (p=0.045), and MMP-9/TIMP-1 ratio (p=0.007). Significant and positive correlations between MMP-9 and TIMP-1 (r=0.610, p<or=0.001]), IL-6 and creatine kinase (CK) (r=0.159, p=0.022), and IL-6 and Troponin-I (TnI) (r=0.141, p=0.042) were observed by Spearman's correlations analysis. Logistic regression analysis revealed that IL-6 significantly and independently correlated with the occurrence of STEMI, and IL-6 was an independent predictor for cardiac mortality during a 24-mo follow-up in patients with STEMI. CONCLUSION: The present study indicates that elevated admission level of IL-6, but not of sCD40L, MMP-9, or TIMP-1, might indicate the onset of STEMI, and could provide prognostic value for future cardiac mortality within 2 y in patients with STEMI.
Jing Tan; Qi Hua; Jing Gao; Zhen Xing Fan
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  31     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-09-16     Completed Date:  2009-01-09     Revised Date:  2009-06-17    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  413-8     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2008 Wiley Periodicals, Inc.
Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
CD40 Ligand / blood
Inflammation Mediators / blood*
Interleukin-6 / blood
Logistic Models
Matrix Metalloproteinase 9 / blood
Middle Aged
Myocardial Infarction / blood*,  diagnosis,  etiology,  mortality
Risk Factors
Tissue Inhibitor of Metalloproteinase-1 / blood
Reg. No./Substance:
0/Biological Markers; 0/Inflammation Mediators; 0/Interleukin-6; 0/Tissue Inhibitor of Metalloproteinase-1; 147205-72-9/CD40 Ligand; EC Metalloproteinase 9
Comment In:
Clin Cardiol. 2009 May;32(5):288   [PMID:  19452490 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endogenous B-type natriuretic peptide: a limb of the regulatory response to acutely decompensated he...
Next Document:  Reclassification of patients for aggressive cholesterol treatment: additive value of multislice coro...